Curative Biotechnology

Curative Biotechnology Tangible Book Value per Share

The Tangible Book Value per Share of Curative Biotechnology (CUBT) as of Oct 17, 2026 is -0.01 USD.

Tangible Book Value per Share

-0.01USD

YoY

23.90%

Last updated:

Tangible Book Value per Share of Curative Biotechnology is 2025 -0.01 USD. Tangible Book Value per Share of Curative Biotechnology was 2024 -0.00 USD. It decreases by 23.90% lower compared to the previous year.

The Curative Biotechnology Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
-0.00 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
-0.01 USD
The Curative Biotechnology Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
-0.01USD+23.90%
-0.00USD+56.32%
-0.00USD+18.27%
-0.00USD+85.32%
-0.00USD-70.14%
-0.00USD+1,013.92%
-0.00USD-37.46%
-0.00USD+4.54%
-0.00USD+3.61%
-0.00USD+2.81%
-0.00USD-26.06%
-0.00USD-78.32%
-0.00USD-2.70%
-0.00USD-51.32%
-0.01USD-58.92%
-0.02USD+560.71%
-0.00USD-104.58%
0.06USD-87.08%
0.47USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Curative Biotechnology Stock analysis

What does Curative Biotechnology do? Curative Biotechnology Inc, based in Boca Raton, Florida, provides software solutions for the healthcare market and develops therapeutic drug candidates for rare diseases. The company focuses on degenerative eye disease, infectious disease, and neuro oncology, with its primary pipeline product being a Metformin Reformulation for age-related macular degeneration. It also has ongoing programs including IMT504 for rabies and CURB906 for cancer treatment, operating with a small team of four employees since its 2001 IPO. Curative Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curative Biotechnology stock

Tangible Book Value per Share of Curative Biotechnology is -0.01 USD in 2025.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Curative Biotechnology since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Curative Biotechnology

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Curative Biotechnology